Eric L. Simpson, MD; Lawrence F. Eichenfield, MD; Javier Alonso-Llamazares, MD, PhD; et al.
open access
JAMA Dermatol. 2024;160(11):1161-1170. doi:10.1001/jamadermatol.2024.3121
Two randomized clinical trials evaluate the efficacy and safety of once-daily roflumilast cream, 0.15%, vs vehicle cream in patients with atopic dermatitis.
Itzel Guadalupe Elizalde-Jiménez, MD; Fernando Gerardo Ruiz-Hernández, MD; Silvia Angélica Carmona-Cruz, MD; et al.
has audio
JAMA Dermatol. 2024;160(11):1171-1181. doi:10.1001/jamadermatol.2024.3360
This meta-analysis assesses the antimicrobial susceptibility of Staphylococcus aureus in individuals with atopic dermatitis and analyzes differences according to the income level of country of origin and the data collection period.
-
Podcast:
Global Antimicrobial Susceptibility Patterns of Staphylococcus aureus in Atopic Dermatitis
Daying Zhang, PhD; Tiechi Lei, MD; Lanying Qin, MM; et al.
open access
JAMA Dermatol. 2024;160(11):1182-1191. doi:10.1001/jamadermatol.2024.3410
This randomized clinical trial evaluated crisugabalin, 40 mg/d, or crisugabalin, 80 mg/d, compared to placebo in terms of patient outcomes and tolerability.
Po-Yi Chou, MD, MMS; Chia-Ling Yu, MS; Chiao-Ni Wen, MS; et al.
JAMA Dermatol. 2024;160(11):1192-1200. doi:10.1001/jamadermatol.2024.3425
This systematic review and meta-analysis investigates the correlation between bullous pemphigoid disease severity and serum levels of antibodies targeting antigens BP180 and BP230.
Hildur Helgadottir, MD, PhD; Rasmus Mikiver, BSc; Karina Schultz, MD; et al.
open access
JAMA Dermatol. 2024;160(11):1201-1210. doi:10.1001/jamadermatol.2024.3514
This cohort study assesses incidence of primary invasive cutaneous malignant melanoma and mortality trends in Sweden, focusing on the population younger than the mean age of melanoma onset.
Aaron Bao, BA; Aasheen Qadri, BS; Aditi Gadre, BS; et al.
JAMA Dermatol. 2024;160(11):1211-1219. doi:10.1001/jamadermatol.2024.3062
This case series investigates the associations of low-dose oral metformin with clinical symptoms and scalp gene expression patterns in patients with central centrifugal cicatricial alopecia.